Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 1, no: 5 |
NetGPI | no | yes: 0, no: 6 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 7 |
GO:0110165 | cellular anatomical entity | 1 | 7 |
Related structures:
AlphaFold database: E9B5W5
Term | Name | Level | Count |
---|---|---|---|
GO:0006629 | lipid metabolic process | 3 | 7 |
GO:0006644 | phospholipid metabolic process | 4 | 7 |
GO:0006793 | phosphorus metabolic process | 3 | 7 |
GO:0006796 | phosphate-containing compound metabolic process | 4 | 7 |
GO:0008152 | metabolic process | 1 | 7 |
GO:0008610 | lipid biosynthetic process | 4 | 7 |
GO:0008654 | phospholipid biosynthetic process | 5 | 7 |
GO:0009058 | biosynthetic process | 2 | 7 |
GO:0009987 | cellular process | 1 | 7 |
GO:0019637 | organophosphate metabolic process | 3 | 7 |
GO:0044237 | cellular metabolic process | 2 | 7 |
GO:0044238 | primary metabolic process | 2 | 7 |
GO:0044255 | cellular lipid metabolic process | 3 | 7 |
GO:0071704 | organic substance metabolic process | 2 | 7 |
GO:0090407 | organophosphate biosynthetic process | 4 | 7 |
GO:1901576 | organic substance biosynthetic process | 3 | 7 |
GO:0006650 | glycerophospholipid metabolic process | 5 | 1 |
GO:0006656 | phosphatidylcholine biosynthetic process | 5 | 1 |
GO:0006807 | nitrogen compound metabolic process | 2 | 1 |
GO:0044249 | cellular biosynthetic process | 3 | 1 |
GO:0045017 | glycerolipid biosynthetic process | 4 | 1 |
GO:0046470 | phosphatidylcholine metabolic process | 4 | 1 |
GO:0046474 | glycerophospholipid biosynthetic process | 5 | 1 |
GO:0046486 | glycerolipid metabolic process | 4 | 1 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 1 |
GO:1901566 | organonitrogen compound biosynthetic process | 4 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 7 |
GO:0016740 | transferase activity | 2 | 7 |
GO:0016746 | acyltransferase activity | 3 | 7 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 220 | 224 | PF00656 | 0.576 |
CLV_NRD_NRD_1 | 110 | 112 | PF00675 | 0.679 |
CLV_NRD_NRD_1 | 216 | 218 | PF00675 | 0.439 |
CLV_NRD_NRD_1 | 320 | 322 | PF00675 | 0.457 |
CLV_NRD_NRD_1 | 350 | 352 | PF00675 | 0.408 |
CLV_NRD_NRD_1 | 354 | 356 | PF00675 | 0.414 |
CLV_NRD_NRD_1 | 418 | 420 | PF00675 | 0.502 |
CLV_PCSK_KEX2_1 | 110 | 112 | PF00082 | 0.679 |
CLV_PCSK_KEX2_1 | 216 | 218 | PF00082 | 0.447 |
CLV_PCSK_KEX2_1 | 320 | 322 | PF00082 | 0.457 |
CLV_PCSK_KEX2_1 | 350 | 352 | PF00082 | 0.408 |
CLV_PCSK_KEX2_1 | 354 | 356 | PF00082 | 0.414 |
CLV_PCSK_KEX2_1 | 360 | 362 | PF00082 | 0.431 |
CLV_PCSK_PC1ET2_1 | 360 | 362 | PF00082 | 0.503 |
CLV_PCSK_PC7_1 | 350 | 356 | PF00082 | 0.315 |
CLV_PCSK_SKI1_1 | 101 | 105 | PF00082 | 0.684 |
CLV_PCSK_SKI1_1 | 180 | 184 | PF00082 | 0.394 |
CLV_PCSK_SKI1_1 | 210 | 214 | PF00082 | 0.386 |
CLV_PCSK_SKI1_1 | 321 | 325 | PF00082 | 0.447 |
CLV_PCSK_SKI1_1 | 361 | 365 | PF00082 | 0.495 |
CLV_PCSK_SKI1_1 | 420 | 424 | PF00082 | 0.376 |
CLV_PCSK_SKI1_1 | 425 | 429 | PF00082 | 0.356 |
DOC_CYCLIN_yCln2_LP_2 | 386 | 392 | PF00134 | 0.596 |
DOC_MAPK_gen_1 | 124 | 133 | PF00069 | 0.503 |
DOC_MAPK_gen_1 | 367 | 375 | PF00069 | 0.657 |
DOC_MAPK_MEF2A_6 | 127 | 135 | PF00069 | 0.491 |
DOC_PP1_RVXF_1 | 328 | 334 | PF00149 | 0.653 |
DOC_PP2B_LxvP_1 | 117 | 120 | PF13499 | 0.532 |
DOC_PP2B_PxIxI_1 | 457 | 463 | PF00149 | 0.397 |
DOC_USP7_MATH_1 | 263 | 267 | PF00917 | 0.683 |
DOC_USP7_MATH_1 | 390 | 394 | PF00917 | 0.757 |
DOC_USP7_UBL2_3 | 360 | 364 | PF12436 | 0.638 |
DOC_USP7_UBL2_3 | 494 | 498 | PF12436 | 0.693 |
DOC_WW_Pin1_4 | 104 | 109 | PF00397 | 0.450 |
DOC_WW_Pin1_4 | 385 | 390 | PF00397 | 0.626 |
DOC_WW_Pin1_4 | 397 | 402 | PF00397 | 0.713 |
LIG_14-3-3_CanoR_1 | 190 | 198 | PF00244 | 0.572 |
LIG_14-3-3_CanoR_1 | 210 | 219 | PF00244 | 0.450 |
LIG_14-3-3_CanoR_1 | 279 | 285 | PF00244 | 0.793 |
LIG_14-3-3_CanoR_1 | 320 | 326 | PF00244 | 0.588 |
LIG_14-3-3_CanoR_1 | 404 | 409 | PF00244 | 0.625 |
LIG_14-3-3_CanoR_1 | 434 | 440 | PF00244 | 0.608 |
LIG_Actin_WH2_2 | 281 | 298 | PF00022 | 0.764 |
LIG_APCC_ABBA_1 | 427 | 432 | PF00400 | 0.684 |
LIG_BRCT_BRCA1_1 | 156 | 160 | PF00533 | 0.363 |
LIG_BRCT_BRCA1_1 | 455 | 459 | PF00533 | 0.436 |
LIG_FHA_1 | 301 | 307 | PF00498 | 0.742 |
LIG_FHA_1 | 442 | 448 | PF00498 | 0.558 |
LIG_FHA_2 | 148 | 154 | PF00498 | 0.430 |
LIG_FHA_2 | 343 | 349 | PF00498 | 0.599 |
LIG_FHA_2 | 379 | 385 | PF00498 | 0.736 |
LIG_IRF3_LxIS_1 | 131 | 136 | PF10401 | 0.423 |
LIG_LIR_Apic_2 | 97 | 102 | PF02991 | 0.578 |
LIG_LIR_Gen_1 | 112 | 122 | PF02991 | 0.502 |
LIG_LIR_Gen_1 | 136 | 145 | PF02991 | 0.463 |
LIG_LIR_Gen_1 | 156 | 166 | PF02991 | 0.419 |
LIG_LIR_Gen_1 | 187 | 196 | PF02991 | 0.562 |
LIG_LIR_Gen_1 | 282 | 290 | PF02991 | 0.770 |
LIG_LIR_Gen_1 | 35 | 44 | PF02991 | 0.411 |
LIG_LIR_Gen_1 | 456 | 467 | PF02991 | 0.450 |
LIG_LIR_Nem_3 | 112 | 117 | PF02991 | 0.482 |
LIG_LIR_Nem_3 | 125 | 131 | PF02991 | 0.391 |
LIG_LIR_Nem_3 | 136 | 140 | PF02991 | 0.454 |
LIG_LIR_Nem_3 | 156 | 161 | PF02991 | 0.389 |
LIG_LIR_Nem_3 | 168 | 172 | PF02991 | 0.333 |
LIG_LIR_Nem_3 | 18 | 24 | PF02991 | 0.411 |
LIG_LIR_Nem_3 | 192 | 198 | PF02991 | 0.599 |
LIG_LIR_Nem_3 | 282 | 288 | PF02991 | 0.779 |
LIG_LIR_Nem_3 | 324 | 328 | PF02991 | 0.567 |
LIG_LIR_Nem_3 | 35 | 39 | PF02991 | 0.411 |
LIG_LIR_Nem_3 | 454 | 460 | PF02991 | 0.454 |
LIG_LIR_Nem_3 | 97 | 103 | PF02991 | 0.535 |
LIG_LYPXL_yS_3 | 457 | 460 | PF13949 | 0.411 |
LIG_PCNA_yPIPBox_3 | 236 | 246 | PF02747 | 0.710 |
LIG_PCNA_yPIPBox_3 | 41 | 51 | PF02747 | 0.513 |
LIG_Pex14_1 | 339 | 343 | PF04695 | 0.583 |
LIG_Pex14_1 | 74 | 78 | PF04695 | 0.511 |
LIG_Pex14_2 | 158 | 162 | PF04695 | 0.411 |
LIG_Pex14_2 | 342 | 346 | PF04695 | 0.597 |
LIG_Pex14_2 | 426 | 430 | PF04695 | 0.606 |
LIG_SH2_CRK | 285 | 289 | PF00017 | 0.680 |
LIG_SH2_CRK | 312 | 316 | PF00017 | 0.708 |
LIG_SH2_CRK | 325 | 329 | PF00017 | 0.495 |
LIG_SH2_GRB2like | 228 | 231 | PF00017 | 0.646 |
LIG_SH2_NCK_1 | 228 | 232 | PF00017 | 0.698 |
LIG_SH2_SRC | 132 | 135 | PF00017 | 0.480 |
LIG_SH2_SRC | 228 | 231 | PF00017 | 0.702 |
LIG_SH2_SRC | 9 | 12 | PF00017 | 0.222 |
LIG_SH2_STAT3 | 24 | 27 | PF00017 | 0.619 |
LIG_SH2_STAT5 | 132 | 135 | PF00017 | 0.450 |
LIG_SH2_STAT5 | 144 | 147 | PF00017 | 0.353 |
LIG_SH2_STAT5 | 195 | 198 | PF00017 | 0.565 |
LIG_SH2_STAT5 | 31 | 34 | PF00017 | 0.511 |
LIG_SH2_STAT5 | 36 | 39 | PF00017 | 0.336 |
LIG_SH2_STAT5 | 9 | 12 | PF00017 | 0.411 |
LIG_SH3_3 | 128 | 134 | PF00018 | 0.485 |
LIG_TYR_ITIM | 29 | 34 | PF00017 | 0.530 |
LIG_TYR_ITIM | 323 | 328 | PF00017 | 0.577 |
LIG_UBA3_1 | 13 | 20 | PF00899 | 0.404 |
LIG_UBA3_1 | 48 | 56 | PF00899 | 0.487 |
LIG_WRC_WIRS_1 | 155 | 160 | PF05994 | 0.419 |
LIG_WRC_WIRS_1 | 185 | 190 | PF05994 | 0.546 |
LIG_WRC_WIRS_1 | 343 | 348 | PF05994 | 0.595 |
MOD_CDK_SPxK_1 | 104 | 110 | PF00069 | 0.488 |
MOD_CDK_SPxxK_3 | 104 | 111 | PF00069 | 0.475 |
MOD_CDK_SPxxK_3 | 397 | 404 | PF00069 | 0.680 |
MOD_CK1_1 | 283 | 289 | PF00069 | 0.747 |
MOD_CK2_1 | 147 | 153 | PF00069 | 0.435 |
MOD_CK2_1 | 342 | 348 | PF00069 | 0.596 |
MOD_CK2_1 | 374 | 380 | PF00069 | 0.666 |
MOD_CK2_1 | 397 | 403 | PF00069 | 0.685 |
MOD_Cter_Amidation | 417 | 420 | PF01082 | 0.507 |
MOD_GlcNHglycan | 120 | 123 | PF01048 | 0.536 |
MOD_GlcNHglycan | 213 | 216 | PF01048 | 0.391 |
MOD_GlcNHglycan | 265 | 268 | PF01048 | 0.481 |
MOD_GlcNHglycan | 376 | 379 | PF01048 | 0.492 |
MOD_GlcNHglycan | 468 | 471 | PF01048 | 0.572 |
MOD_GlcNHglycan | 65 | 68 | PF01048 | 0.652 |
MOD_GSK3_1 | 265 | 272 | PF00069 | 0.713 |
MOD_GSK3_1 | 279 | 286 | PF00069 | 0.668 |
MOD_GSK3_1 | 374 | 381 | PF00069 | 0.681 |
MOD_N-GLC_1 | 229 | 234 | PF02516 | 0.442 |
MOD_N-GLC_1 | 238 | 243 | PF02516 | 0.367 |
MOD_N-GLC_1 | 80 | 85 | PF02516 | 0.701 |
MOD_NEK2_1 | 160 | 165 | PF00069 | 0.506 |
MOD_NEK2_1 | 211 | 216 | PF00069 | 0.674 |
MOD_NEK2_1 | 238 | 243 | PF00069 | 0.665 |
MOD_NEK2_1 | 280 | 285 | PF00069 | 0.766 |
MOD_NEK2_1 | 295 | 300 | PF00069 | 0.577 |
MOD_NEK2_1 | 342 | 347 | PF00069 | 0.594 |
MOD_NEK2_1 | 39 | 44 | PF00069 | 0.513 |
MOD_NEK2_1 | 441 | 446 | PF00069 | 0.535 |
MOD_NEK2_1 | 451 | 456 | PF00069 | 0.403 |
MOD_NEK2_1 | 499 | 504 | PF00069 | 0.661 |
MOD_NEK2_1 | 85 | 90 | PF00069 | 0.534 |
MOD_PIKK_1 | 295 | 301 | PF00454 | 0.751 |
MOD_PIKK_1 | 441 | 447 | PF00454 | 0.558 |
MOD_PKA_1 | 110 | 116 | PF00069 | 0.472 |
MOD_PKA_2 | 110 | 116 | PF00069 | 0.475 |
MOD_PKA_2 | 189 | 195 | PF00069 | 0.546 |
MOD_PKA_2 | 295 | 301 | PF00069 | 0.751 |
MOD_PKA_2 | 403 | 409 | PF00069 | 0.643 |
MOD_Plk_1 | 238 | 244 | PF00069 | 0.654 |
MOD_Plk_2-3 | 218 | 224 | PF00069 | 0.651 |
MOD_Plk_4 | 154 | 160 | PF00069 | 0.419 |
MOD_Plk_4 | 202 | 208 | PF00069 | 0.602 |
MOD_Plk_4 | 248 | 254 | PF00069 | 0.673 |
MOD_Plk_4 | 280 | 286 | PF00069 | 0.741 |
MOD_Plk_4 | 39 | 45 | PF00069 | 0.436 |
MOD_Plk_4 | 435 | 441 | PF00069 | 0.610 |
MOD_ProDKin_1 | 104 | 110 | PF00069 | 0.451 |
MOD_ProDKin_1 | 385 | 391 | PF00069 | 0.623 |
MOD_ProDKin_1 | 397 | 403 | PF00069 | 0.711 |
MOD_SUMO_for_1 | 363 | 366 | PF00179 | 0.693 |
TRG_DiLeu_BaLyEn_6 | 113 | 118 | PF01217 | 0.525 |
TRG_DiLeu_BaLyEn_6 | 241 | 246 | PF01217 | 0.507 |
TRG_DiLeu_BaLyEn_6 | 276 | 281 | PF01217 | 0.799 |
TRG_ENDOCYTIC_2 | 132 | 135 | PF00928 | 0.407 |
TRG_ENDOCYTIC_2 | 195 | 198 | PF00928 | 0.565 |
TRG_ENDOCYTIC_2 | 228 | 231 | PF00928 | 0.702 |
TRG_ENDOCYTIC_2 | 285 | 288 | PF00928 | 0.720 |
TRG_ENDOCYTIC_2 | 31 | 34 | PF00928 | 0.565 |
TRG_ENDOCYTIC_2 | 312 | 315 | PF00928 | 0.693 |
TRG_ENDOCYTIC_2 | 325 | 328 | PF00928 | 0.506 |
TRG_ENDOCYTIC_2 | 343 | 346 | PF00928 | 0.581 |
TRG_ENDOCYTIC_2 | 36 | 39 | PF00928 | 0.451 |
TRG_ENDOCYTIC_2 | 408 | 411 | PF00928 | 0.595 |
TRG_ENDOCYTIC_2 | 457 | 460 | PF00928 | 0.411 |
TRG_ER_diArg_1 | 109 | 111 | PF00400 | 0.476 |
TRG_ER_diArg_1 | 319 | 321 | PF00400 | 0.652 |
TRG_ER_diArg_1 | 349 | 351 | PF00400 | 0.681 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A3S7X8X9 | Leishmania donovani | 94% | 96% |
A0A422NIA4 | Trypanosoma rangeli | 43% | 93% |
A4HMB6 | Leishmania braziliensis | 82% | 100% |
A4IAY2 | Leishmania infantum | 94% | 96% |
E9AER0 | Leishmania major | 93% | 100% |